Short chain carboxylic acids are well known as the precursors of fatty acid and polyketide biosynthesis. Iso-fatty acids, which are important for the control of membrane fluidity, are formed from branched chain starter units (isovaleryl-CoA and isobutyryl-CoA), which in turn are derived from the degradation of leucine and valine, respectively. Branched chain carboxylic acids are also employed as starter molecules for the biosynthesis of secondary metabolites, e.g. the therapeutically important anthelmintic agent avermectin or the electron transport inhibitor myxothiazol. During our studies on myxothiazol biosynthesis in the myxobacterium, Stigmatella aurantiaca, we detected a novel biosynthetic route to isovaleric acid. After cloning and inactivation of the branched chain keto-acid dehydrogenase complex, which is responsible for the degradation of branched chain amino acids, the strain is still able to produce iso-fatty acids and myxothiazol. Incorporation studies employing deuterated leucine show that it can only serve as precursor in the wild type strain, but not in the esg-mutant. Feeding experiments using 13 C-labelled precursors show that isovalerate is efficiently made from acetate, giving rise to a labelling pattern in myxothiazol that provides evidence for a novel branch of the mevalonate pathway involving the intermediate 3,3-dimethylacryloyl-CoA. 3,3-Dimethylacrylic acid was synthesized in deuterated form and fed to the esg-mutant, resulting in strong incorporation into myxothiazol and iso-fatty acids. Similar experiments employing Myxococcus xanthus revealed that the discovered biosynthetic route described is present in other myxobacteria as well.
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separate enzyme and then oxidatively decarboxylated by the branched chain keto acid dehydrogenase (Bkd) complex, resulting in IVA-CoA, IBA-CoA and 2MBA-CoA, respectively (3) . These precursors are not only employed in iso-FA biosynthesis but can as well serve as starter molecules for the formation of polyketides. These represent a group of immensely diverse natural products with biological activity, many of which are widely used in the clinic. Examples of polyketides with a branched chain carboxylic acid starter moiety are the anthelmintic agent avermectin produced by Streptomyces avermitilis (4) , the clinically used virginiamycin group of antibiotics and the electron transport inhibitors myxothiazol (5, 6 ) (compare figure 4) and myxalamid (7, 8) from the myxobacterium Stigmatella aurantiaca. During our studies on the biosynthesis of the latter secondary metabolites in myxobacteria we became interested in the Bkd locus of S. aurantiaca DW4/3-1, because it seems to regulate the production of starter molecules for primary metabolism (iso-FA) and secondary metabolism. In addition, myxobacteria show a so called social behaviour which culminates in the formation of multicellular fruiting bodies under starvation conditions (9) . The model organism Myxococcus xanthus has been studied extensively in order to reveal the mechanisms underlying this process. It has been shown in M.
xanthus that a knockout of the bkd gene leads to a development-defective phenotype (10, 11) . The signal interrupted is called the E-signal, the nature and function of which is not well understood. Because the mutant was detected in a screen for developmentally defective strains, the gene affected was called esg (for E-signal gene) instead of bkd. Recently, Shimkets and coworkers have shed light on the nature of the signal itself and proposed that it might be a lipid (12, 13) .
by guest on http://www.jbc.org/ Downloaded from during the development of the bacterium, we suspected the encoding gene to be a good candidate to study, in order to reveal the connections not only between primary and secondary metabolism but also to development in myxobacteria. Additionally, FA analyses of esg-mutants of M. xanthus published by the Shimkets and the Downard groups showed that the mutant strain was still able to produce iso-FA, which left both groups with the question how this might be accomplished. In general, M. xanthus contains an immense diversity of FA, which include saturated, unsaturated, branchedchain and hydroxylated species (14) .
We here describe the cloning and inactivation of the esg-gene in S. aurantiaca DW4/3-1 and provide evidence for an unexpected biosynthetic pathway complementing Bkd disruption in myxobacteria. This pathway was characterized in feeding experiments with labelled precursors and intermediates. It must be taken into consideration when analysing the nature of the developmental E-signal in M. xanthus and S. aurantiaca.
Materials and Methods
DNA manipulations, analyses, sequencing, and PCR. Southern analysis of genomic DNA was performed using the standard protocol for homologous probes of the DIG High Prime DNA Labeling and Detection Starter Kit II (Roche Molecular Biochemicals). PCR was carried out using Taq Polymerase (Gibco BRL) according to the manufacturer`s protocol. 5% DMSO was added to the mixture. Conditions for amplification with the Eppendorf mastercycler gradient were as follows: denaturation 30 sec at 95°C, annealing 30 sec at 55°C and extension 45 sec at 72°C; 30 cycles and a final extension at 72°C for 10 min. Sequencing was performed using the Big Dye RR Terminator Cycle Sequencing Kit (PE Biosystems), the gels were run on ABI-377 sequencers. All other DNA manipulations were performed according to standard protocols (15) . Amino acid and DNA alignments were done using the programs of the Lasergene software package (DNASTAR Inc.) and Clustal W (16).
Cloning and inactivation of the esg-locus of S. aurantiaca DW4/3-1. A set of three oligonucleotide combinations designed to bind to the M. xanthus esg-sequence enabled the PCR-amplification of a esg-gene fragment from genomic DNA of S.
with the probe and next cloned into pSK(-) (Stratagene), resulting in pEBS22. The sequence of the insert was obtained via primer walking.
Based on the sequence, a 476 bp fragment of the β-subunit of the esg-complex was amplified (using oligonucleotides esgup and esgd2) and cloned into a vector harbouring a kanamycin resistance gene (pCR2.1/TOPO). The resulting plasmid pEBS7 was electroporated into S. aurantiaca DW4/3-1 (6, 17) . The correctness of the integration of the plasmid into the chromosome of kanamycin resistant colonies (S. aurantiaca EBS7) was verified using Southern hybridisation (data not shown).
Fatty acid and myxothiazol analysis. Fatty acid methyl esters were obtained from 40 mg cells scraped from Petri dishes by saponification, methylation and extraction using minor modifications of the methods of Miller (18) and Kuykendall (19) . The fatty acid methyl ester mixtures were separated using a Sherlock Microbial Identification (Microbial ID). The gas chromatographic parameters were as follows: carrier gas, ultra-high-purity hydrogen; column head pressure 60 kPa; injection volume 2 µl; column split ratio, 100:1; septum purge 5 ml/min; column temperature, 170 to 270°C at 5°C/min; injection port temperature, 250°C; and detector temperature, 300°C. FA analysis using GC-MS was done on a Finnigan MAT GCQ gas chromatograph (San Jose, CA) connected to an ion trap mass spectrometer running in the EI mode (70 eV) under similar conditions as described above. Myxothiazol was isolated from S. aurantiaca DW4/3-1 and its decendants by repeated methanol extraction of cells and adsorber resin (see below) followed by evaporation of the solvent. The resulting aqueous phase was extracted with ethyl acetate and the organic solvent was evaporated to dryness. The combined residues were dissolved in a small amount of methanol and extracted repeatedly with n-heptane. The resulting methanolic solution was concentrated under reduced pressure and subjected to preparative RP-HPLC on a Nucleodur 100-10 C18 EC column (259 mm length/21 mm Ø (Macherey & Nagel, Düren, Germany); solvent: methanol/water 8:2 with a flow rate of 12 ml/min; detection at 234 nm) resulting in 2-6 mg/l of myxothiazol. 13 C-NMR spectra were recorded on a Bruker AMX400 at 100 MHz in CD3OD with the solvent as internal standard.
Feeding experiments employing precursors. Feeding experiments using 13 C-acetate were performed with S. aurantiaca in one or two 400 ml cultures of probione medium 
Synthesis of 3,3-Dimethyl-d6-acrylic acid ([D6]-DMAA] Ethyl 3,3-Dimethyl-d6-acrylate:
To a solution of diisopropylamine (1.5 ml, 10.8 mmol) in 20 ml of anhydrous THF was added 2.5 M butyllithium solution (4.3 ml,10.8 mmol) in hexane at -15°C under an argon atmosphere and the mixture was stirred for 15 min at room temperature. It was then cooled to -78°C and 2.16 ml (10.8 mmol) of triethylphosphonoacetate was added slowly. The reaction mixture was allowed to warm to room temperature for 30 min and then cooled again to -78°C. Acetone-d6 [1.6 ml (21.6 mmol)] of was then added and the mixture was stirred at room temperature for 1.5 h. The reaction was quenched with water at -78°C and the mixture allowed to warm to room temperature.
The product was extracted with three portions of 10 ml of ethyl ether and the combined organic layer was washed with brine, dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The resulting residue was purified by silica gel column chromatography (eluent: hexane/ethyl ether = 9:1, v/v). 
3,3-Dimethyl-d6-acrylic acid ([D6]DMAA):
To a solution of ethyl-3,3-dimethyl-3,3-d6-acrylate (1.1 g, 8.2 mmol) in 3 ml of methanol and 4.8 ml of THF was added 8 ml of 2M LiOH solution. The mixture was stirred for 6 h at room temperature. The organic solvent was removed in vacuo and 1N
HCl solution was added to adjust the pH to 2~3. The product was extracted with 5 portions of 15 ml of ethyl acetate and the combined organic layer was washed with brine, dried over anhydrous magnesium sulfate and concentrated under reduced
Results

Cloning and inactivation of the esg-locus from S. aurantiaca DW4/3-1
We became interested in the branched chain keto acid dehydrogenase gene locus from S. aurantiaca DW4/3-1, because of the possibility to use it for mutasynthesis in order to generate novel myxothiazol derivatives. We speculated that inactivation of the encoding genes would result in an inability of the bacteria to degrade leucine, which would in turn lead to a lack of precursors (IVA-CoA) for secondary metabolite production and therefore shut down myxothiazol biosynthesis. Feeding of alternative starter units to the esg-mutant was speculated to result in the formation of novel myxothiazols.
Cloning of the esg-locus from S. aurantiaca DW4/3-1 was performed based on the known esg-sequence from M. xanthus (21) . A 3 kbp fragment was sequenced, which encodes the α-and the β-subunit of the Bkd complex. The α−subunit comprises 885 bp and starts with ATG, which is preceded by a putative ribosome binding site (GAGGAG). A 2 bp intergenic region can be found between the α-and the β-subunit. Secondary metabolite production was analysed as described previously (6) .
Myxothiazol is still produced in the esg-mutant. Nevertheless, an approximately threefold decrease in productivity was observed (as judged by the comparison of the peak areas representing myxothiazol in HPLC analysis).
The analysis of the fatty acid composition of both S. aurantiaca strains revealed some striking differences compared to the fatty acid analysis of M. xanthus and the corresponding esg-mutant Ω258. In general, production of leucine-and valinederived fatty acids was decreased in the esg-mutants, whereas the production of saturated and unsaturated fatty acids was increased (figure 2). Feeding of the short chain carboxylic acids IVA, IBA and 2MBA to the S. aurantiaca DW4/3-1 esgmutant was performed and resulted in an almost complete restoration of wild type fatty acid levels in the IVA feeding experiment. Addition of IBA did not result in complete restoration, whereas 2MBA feeding had no effect (see figure 2) . Addition of all three acids abolished growth, whereas the addition of a single compound had no effect on the cell count after 48 h. A time course study revealed that the fatty acid composition does not differ significantly over time (cells were harvested after 15, 24, 39 and 48 h prior to the analysis). Furthermore, feeding of IVA, IBA or 2MBA to the wild type had no effect on the fatty acid composition (data not shown).
Analysis of fatty acid composition in M. xanthus DK1622 and strain Ω258 was performed as well, revealing as expected an enrichment of iso-even FA, iso-odd FA and ante-iso FA after addition of IBA, IVA and 2MBA, respectively [data not shown, compare (13, 21) ].
An approximate restoration of wild type levels of fatty acids could only be seen in IVA and DMAA fed mutants. Thus, DMAA could replace the effect of IVA in M.
xanthus and in S. aurantiaca mutants.
Feeding of IVA had been reported to increase the amount of iso-odd FA (mostly FA iso 15:0) in the M. xanthus esg-mutant twofold, whereas FA 16:1 ω5c was dramatically reduced under these conditions (13) . We only observe an increase of isoodd FA by a factor of 1.5 (Ω258, data not shown), which compares very well to the data reported by the Downard group (21). In S. aurantiaca, only restoration but no increase above wild type levels of iso-odd FA can be detected in the esg-mutant (figure 2). A significant decrease of FA 16:1 ω5c below wild type level was not detected, neither in M. xanthus nor in S. aurantiaca esg-mutants after IVA feeding.
Search for an esg-isogene
Because inactivation of the esg-gene did not result in loss of production of myxothiazol and iso-fatty acids, we suspected the strain to carry an isogene of esg.
Comparable results regarding iso-FA production in M. xanthus esg-mutants have led to similar speculations (10,13). Based on conserved sequences within known bkd genes, degenerate primers were constructed in order to amplify genomic sequences encoding further bkd genes. In addition, Southern blot analyses under low stringency conditions were performed using the esg-gene as a probe (data not shown (table 1) , whereas in the esg-mutant the incorporation was almost half of the incorporation of other malonyl-CoA derived carbon atoms ( figure 4, table 1 ).
The labelling pattern corresponds to intact incorporation of acetate units from C1 to C2 and from C3 to C4 of the IVA starter molecule [identical to C10-C11 and C12-C13 (or C12-C14; C13 and C14 cannot be distinguished via NMR) in myxothiazol; see figure 4 ]. The methylbranch carbon (C14 or C13) is derived from the C2 of acetate.
Synthesis of and feeding experiments with [D6]3,3-dimethylacrylic acid ([D6]DMAA)
From the labelling pattern observed, a hypothetical pathway to IVA branching from the mevalonate biosynthetic route is postulated as shown in figure 5 . and IVA need to be activated in the cell by an CoA ligase, which has already been speculated to be present in M. xanthus (10, 13) .
Another example for a previous non-textbook biosynthetic pathway has been extensively studied recently and is responsible for the generation of isopentenyl pyrophosphate independently of mevalonate (24) . The data presented here show again that standard biochemistry does not always apply in nature and provide further evidence for the assumption that novel biochemistry can still be detected by close analysis of not only secondary but also primary metabolism.
The pathway proposed in figure 5 builds up myxothiazol and iso-FA from DMA-CoA directly. Alternatively, IVA could be generated from 3-methyl-3-butenoyl-CoA after isomerization of the endo to the exo-double bond. The latter compound is speculated to be derived from HMG-CoA by decarboxylation and dehydration (similar to isopentenylpyrophosphate from activated mevalonic acid). DMAA could as well be formed from HMG-CoA via 3-methyl-glutaconyl-CoA (after dehydration) and subsequent decarboxylation.
Intriguingly, DMAA is incorporated into secondary metabolites and primary metabolites in form of not only iso-odd FA but also iso-even FA, which came as a surprise. We therefore speculate that DMAA can serve as precursor for IBA biosynthesis as well (e.g via hydroxylation, dehydrogenation and oxidative decarboxylation of IVA and subsequent activation of IBA).
It will be interesting to see whether the pathway described is present in all myxobacteria or even in other organisms. This article cites 0 references, 0 of which can be accessed free at
